Chapter title |
Comorbidities in Heart Failure
|
---|---|
Chapter number | 27 |
Book title |
Heart Failure
|
Published in |
Handbook of experimental pharmacology, April 2017
|
DOI | 10.1007/164_2017_27 |
Pubmed ID | |
Book ISBNs |
978-3-31-959658-7, 978-3-31-959659-4
|
Authors |
van der Wal, Haye H., van Deursen, Vincent M., van der Meer, Peter, Voors, Adriaan A., Haye H. van der Wal, Vincent M. van Deursen, Peter van der Meer, Adriaan A. Voors, Wal, Haye H., Deursen, Vincent M., Meer, Peter |
Abstract |
Comorbidities frequently accompany chronic heart failure (HF), contributing to increased morbidity and mortality, and an impaired quality of life. We describe the prevalence of several high-impact comorbidities in chronic HF patients and their impact on morbidity and mortality. Furthermore, we try to explain the underlying pathophysiological processes and the complex interaction between chronic HF and specific comorbidities. Although common risk factors are likely to contribute, it is reasonable to believe that factors associated with HF might cause other comorbidities and vice versa. Potential factors are inflammation, neurohormonal activation, and hemodynamic changes. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 107 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 16 | 15% |
Researcher | 13 | 12% |
Student > Master | 10 | 9% |
Other | 9 | 8% |
Student > Ph. D. Student | 9 | 8% |
Other | 16 | 15% |
Unknown | 34 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 36% |
Nursing and Health Professions | 7 | 7% |
Neuroscience | 5 | 5% |
Psychology | 4 | 4% |
Biochemistry, Genetics and Molecular Biology | 4 | 4% |
Other | 14 | 13% |
Unknown | 35 | 33% |